▶ 調査レポート

止血剤・組織封止剤の世界及び中国市場

• 英文タイトル:Global and China Hemostatic and Tissue Sealing Agents Market Insights, Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。止血剤・組織封止剤の世界及び中国市場 / Global and China Hemostatic and Tissue Sealing Agents Market Insights, Forecast to 2027 / QY2108PAL8532資料のイメージです。• レポートコード:QY2108PAL8532
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、152ページ
• 納品方法:Eメール(納期:1日)
• 産業分類:医療装置
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の当調査資料ではグローバルにおける止血剤・組織封止剤の市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、止血剤・組織封止剤の種類別市場規模(止血、シーラントガム)、用途別市場規模(低侵襲手術、一般外科、その他)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界の止血剤・組織封止剤市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界における止血剤・組織封止剤の種類別市場規模(2016年-2027年):止血、シーラントガム
・世界における止血剤・組織封止剤の用途別市場規模(2016年-2027年):低侵襲手術、一般外科、その他
・止血剤・組織封止剤の中国市場分析
- 止血剤・組織封止剤の中国市場規模(2016年-2027年)
- 中国における止血剤・組織封止剤の主要プレイヤー別市場シェア
- 中国における止血剤・組織封止剤の種類別市場規模:止血、シーラントガム
- 中国における止血剤・組織封止剤の用途別市場規模:低侵襲手術、一般外科、その他
・止血剤・組織封止剤の北米市場(2016年-2027年)
・止血剤・組織封止剤のヨーロッパ市場(2016年-2027年)
・止血剤・組織封止剤のアジア太平洋市場(2016年-2027年)
・止血剤・組織封止剤の中南米市場(2016年-2027年)
・止血剤・組織封止剤の中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:J&J、Baxter、C R Bard、B Braun、Integra Life Sciences、Advance Medical Solution、CSL Behring、CryoLife、Zimmer Biomet、Pfizer、Medtronic、Smith & Nephew、Cohera Medical、Shanghai Haohai Biological Technology Co. Ltd.、Shandong Saikesaisi Biotechnology Co., Ltd、Chang ShaHai Run biological technology Co, LTD
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...

Hemostasis is defined as “the blocking of bleeding or bleeding through blood vessels or other parts of the body”.Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.
In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.

Market Analysis and Insights: Global and China Hemostatic and Tissue Sealing Agents Market
This report focuses on global and China Hemostatic and Tissue Sealing Agents market.
In 2020, the global Hemostatic and Tissue Sealing Agents market size was US$ 2720.2 million and it is expected to reach US$ 3345.5 million by the end of 2027, with a CAGR of 3.0% during 2021-2027. In China the Hemostatic and Tissue Sealing Agents market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Hemostatic and Tissue Sealing Agents Scope and Market Size
Hemostatic and Tissue Sealing Agents market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hemostatic and Tissue Sealing Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Hemostatic and Tissue Sealing Agents market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Hemostatic
Sealant Gum

Segment by Application
Minimally Invasive Surgery
General Surgery
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD

レポート目次

1 Study Coverage
1.1 Hemostatic and Tissue Sealing Agents Product Introduction
1.2 Market by Type
1.2.1 Global Hemostatic and Tissue Sealing Agents Market Size Growth Rate by Type
1.2.2 Hemostatic
1.2.3 Sealant Gum
1.3 Market by Application
1.3.1 Global Hemostatic and Tissue Sealing Agents Market Size Growth Rate by Application
1.3.2 Minimally Invasive Surgery
1.3.3 General Surgery
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Hemostatic and Tissue Sealing Agents Market Size, Estimates and Forecasts
2.1.1 Global Hemostatic and Tissue Sealing Agents Revenue 2016-2027
2.1.2 Global Hemostatic and Tissue Sealing Agents Sales 2016-2027
2.2 Global Hemostatic and Tissue Sealing Agents, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hemostatic and Tissue Sealing Agents Historical Market Size by Region (2016-2021)
2.3.1 Global Hemostatic and Tissue Sealing Agents Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hemostatic and Tissue Sealing Agents Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hemostatic and Tissue Sealing Agents Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hemostatic and Tissue Sealing Agents Sales Forecast by Region (2022-2027)
2.4.2 Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Region (2022-2027)

3 Global Hemostatic and Tissue Sealing Agents Competitor Landscape by Players
3.1 Global Top Hemostatic and Tissue Sealing Agents Manufacturers by Sales
3.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Manufacturer (2016-2021)
3.1.2 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hemostatic and Tissue Sealing Agents Manufacturers by Revenue
3.2.1 Key Hemostatic and Tissue Sealing Agents Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hemostatic and Tissue Sealing Agents Revenue by Manufacturers (2016-2021)
3.2.3 Global Hemostatic and Tissue Sealing Agents Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hemostatic and Tissue Sealing Agents Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hemostatic and Tissue Sealing Agents Revenue in 2020
3.2.6 Global Hemostatic and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hemostatic and Tissue Sealing Agents Price by Manufacturers
3.4 Global Hemostatic and Tissue Sealing Agents Manufacturing Base Distribution, Product Types
3.4.1 Hemostatic and Tissue Sealing Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemostatic and Tissue Sealing Agents Product Type
3.4.3 Date of International Manufacturers Enter into Hemostatic and Tissue Sealing Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Hemostatic and Tissue Sealing Agents Market Size by Type (2016-2021)
4.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2016-2021)
4.1.2 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2016-2021)
4.1.3 Hemostatic and Tissue Sealing Agents Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hemostatic and Tissue Sealing Agents Market Size Forecast by Type (2022-2027)
4.2.1 Global Hemostatic and Tissue Sealing Agents Sales Forecast by Type (2022-2027)
4.2.2 Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Type (2022-2027)
4.2.3 Hemostatic and Tissue Sealing Agents Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Hemostatic and Tissue Sealing Agents Market Size by Application (2016-2021)
5.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2016-2021)
5.1.2 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2016-2021)
5.1.3 Hemostatic and Tissue Sealing Agents Price by Application (2016-2021)
5.2 Hemostatic and Tissue Sealing Agents Market Size Forecast by Application (2022-2027)
5.2.1 Global Hemostatic and Tissue Sealing Agents Sales Forecast by Application (2022-2027)
5.2.2 Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Application (2022-2027)
5.2.3 Global Hemostatic and Tissue Sealing Agents Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Hemostatic and Tissue Sealing Agents Market Size YoY Growth 2016-2027
6.1.1 China Hemostatic and Tissue Sealing Agents Sales YoY Growth 2016-2027
6.1.2 China Hemostatic and Tissue Sealing Agents Revenue YoY Growth 2016-2027
6.1.3 China Hemostatic and Tissue Sealing Agents Market Share in Global Market 2016-2027
6.2 China Hemostatic and Tissue Sealing Agents Market Size by Players (International and Local Players)
6.2.1 China Top Hemostatic and Tissue Sealing Agents Players by Sales (2016-2021)
6.2.2 China Top Hemostatic and Tissue Sealing Agents Players by Revenue (2016-2021)
6.3 China Hemostatic and Tissue Sealing Agents Historic Market Review by Type (2016-2021)
6.3.1 China Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2016-2021)
6.3.2 China Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2016-2021)
6.3.3 China Hemostatic and Tissue Sealing Agents Price by Type (2016-2021)
6.4 China Hemostatic and Tissue Sealing Agents Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Hemostatic and Tissue Sealing Agents Sales Forecast by Type (2022-2027)
6.4.2 China Hemostatic and Tissue Sealing Agents Revenue Forecast by Type (2022-2027)
6.4.3 China Hemostatic and Tissue Sealing Agents Price Forecast by Type (2022-2027)
6.5 China Hemostatic and Tissue Sealing Agents Historic Market Review by Application (2016-2021)
6.5.1 China Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2016-2021)
6.5.2 China Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2016-2021)
6.5.3 China Hemostatic and Tissue Sealing Agents Price by Application (2016-2021)
6.6 China Hemostatic and Tissue Sealing Agents Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Hemostatic and Tissue Sealing Agents Sales Forecast by Application (2022-2027)
6.6.2 China Hemostatic and Tissue Sealing Agents Revenue Forecast by Application (2022-2027)
6.6.3 China Hemostatic and Tissue Sealing Agents Price Forecast by Application (2022-2027)

7 North America
7.1 North America Hemostatic and Tissue Sealing Agents Market Size YoY Growth 2016-2027
7.2 North America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
7.2.1 North America Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021)
7.2.2 North America Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Hemostatic and Tissue Sealing Agents Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hemostatic and Tissue Sealing Agents Market Facts & Figures by Region
8.2.1 Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Region (2016-2021)
8.2.2 Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Hemostatic and Tissue Sealing Agents Market Size YoY Growth 2016-2027
9.2 Europe Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
9.2.1 Europe Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021)
9.2.2 Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Hemostatic and Tissue Sealing Agents Market Size YoY Growth 2016-2027
10.2 Latin America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
10.2.1 Latin America Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021)
10.2.2 Latin America Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Hemostatic and Tissue Sealing Agents Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
11.2.1 Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 J&J
12.1.1 J&J Corporation Information
12.1.2 J&J Description and Business Overview
12.1.3 J&J Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.1.4 J&J Hemostatic and Tissue Sealing Agents Products Offered
12.1.5 J&J Recent Development
12.2 Baxter
12.2.1 Baxter Corporation Information
12.2.2 Baxter Description and Business Overview
12.2.3 Baxter Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baxter Hemostatic and Tissue Sealing Agents Products Offered
12.2.5 Baxter Recent Development
12.3 C R Bard
12.3.1 C R Bard Corporation Information
12.3.2 C R Bard Description and Business Overview
12.3.3 C R Bard Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.3.4 C R Bard Hemostatic and Tissue Sealing Agents Products Offered
12.3.5 C R Bard Recent Development
12.4 B Braun
12.4.1 B Braun Corporation Information
12.4.2 B Braun Description and Business Overview
12.4.3 B Braun Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.4.4 B Braun Hemostatic and Tissue Sealing Agents Products Offered
12.4.5 B Braun Recent Development
12.5 Integra Life Sciences
12.5.1 Integra Life Sciences Corporation Information
12.5.2 Integra Life Sciences Description and Business Overview
12.5.3 Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Integra Life Sciences Hemostatic and Tissue Sealing Agents Products Offered
12.5.5 Integra Life Sciences Recent Development
12.6 Advance Medical Solution
12.6.1 Advance Medical Solution Corporation Information
12.6.2 Advance Medical Solution Description and Business Overview
12.6.3 Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Advance Medical Solution Hemostatic and Tissue Sealing Agents Products Offered
12.6.5 Advance Medical Solution Recent Development
12.7 CSL Behring
12.7.1 CSL Behring Corporation Information
12.7.2 CSL Behring Description and Business Overview
12.7.3 CSL Behring Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.7.4 CSL Behring Hemostatic and Tissue Sealing Agents Products Offered
12.7.5 CSL Behring Recent Development
12.8 CryoLife
12.8.1 CryoLife Corporation Information
12.8.2 CryoLife Description and Business Overview
12.8.3 CryoLife Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CryoLife Hemostatic and Tissue Sealing Agents Products Offered
12.8.5 CryoLife Recent Development
12.9 Zimmer Biomet
12.9.1 Zimmer Biomet Corporation Information
12.9.2 Zimmer Biomet Description and Business Overview
12.9.3 Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Zimmer Biomet Hemostatic and Tissue Sealing Agents Products Offered
12.9.5 Zimmer Biomet Recent Development
12.10 Pfizer
12.10.1 Pfizer Corporation Information
12.10.2 Pfizer Description and Business Overview
12.10.3 Pfizer Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Pfizer Hemostatic and Tissue Sealing Agents Products Offered
12.10.5 Pfizer Recent Development
12.11 J&J
12.11.1 J&J Corporation Information
12.11.2 J&J Description and Business Overview
12.11.3 J&J Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.11.4 J&J Hemostatic and Tissue Sealing Agents Products Offered
12.11.5 J&J Recent Development
12.12 Smith & Nephew
12.12.1 Smith & Nephew Corporation Information
12.12.2 Smith & Nephew Description and Business Overview
12.12.3 Smith & Nephew Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Smith & Nephew Products Offered
12.12.5 Smith & Nephew Recent Development
12.13 Cohera Medical
12.13.1 Cohera Medical Corporation Information
12.13.2 Cohera Medical Description and Business Overview
12.13.3 Cohera Medical Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Cohera Medical Products Offered
12.13.5 Cohera Medical Recent Development
12.14 Shanghai Haohai Biological Technology Co. Ltd.
12.14.1 Shanghai Haohai Biological Technology Co. Ltd. Corporation Information
12.14.2 Shanghai Haohai Biological Technology Co. Ltd. Description and Business Overview
12.14.3 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Shanghai Haohai Biological Technology Co. Ltd. Products Offered
12.14.5 Shanghai Haohai Biological Technology Co. Ltd. Recent Development
12.15 Shandong Saikesaisi Biotechnology Co., Ltd
12.15.1 Shandong Saikesaisi Biotechnology Co., Ltd Corporation Information
12.15.2 Shandong Saikesaisi Biotechnology Co., Ltd Description and Business Overview
12.15.3 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Shandong Saikesaisi Biotechnology Co., Ltd Products Offered
12.15.5 Shandong Saikesaisi Biotechnology Co., Ltd Recent Development
12.16 Chang ShaHai Run biological technology Co, LTD
12.16.1 Chang ShaHai Run biological technology Co, LTD Corporation Information
12.16.2 Chang ShaHai Run biological technology Co, LTD Description and Business Overview
12.16.3 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Chang ShaHai Run biological technology Co, LTD Products Offered
12.16.5 Chang ShaHai Run biological technology Co, LTD Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hemostatic and Tissue Sealing Agents Industry Trends
13.2 Hemostatic and Tissue Sealing Agents Market Drivers
13.3 Hemostatic and Tissue Sealing Agents Market Challenges
13.4 Hemostatic and Tissue Sealing Agents Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemostatic and Tissue Sealing Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Hemostatic and Tissue Sealing Agents Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Hemostatic
Table 3. Major Manufacturers of Sealant Gum
Table 4. Global Hemostatic and Tissue Sealing Agents Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Hemostatic and Tissue Sealing Agents Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Hemostatic and Tissue Sealing Agents Sales by Regions (2016-2021) & (K Units)
Table 7. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Regions (2016-2021)
Table 8. Global Hemostatic and Tissue Sealing Agents Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Hemostatic and Tissue Sealing Agents Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Hemostatic and Tissue Sealing Agents Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Hemostatic and Tissue Sealing Agents Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Hemostatic and Tissue Sealing Agents Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Hemostatic and Tissue Sealing Agents Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Hemostatic and Tissue Sealing Agents Manufacturers by Revenue (US$ Million) in 2020
Table 16. Hemostatic and Tissue Sealing Agents Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Hemostatic and Tissue Sealing Agents Revenue Share by Manufacturers (2016-2021)
Table 18. Global Hemostatic and Tissue Sealing Agents Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Hemostatic and Tissue Sealing Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostatic and Tissue Sealing Agents as of 2020)
Table 20. Key Manufacturers Hemostatic and Tissue Sealing Agents Price (2016-2021) (US$/Unit)
Table 21. Hemostatic and Tissue Sealing Agents Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hemostatic and Tissue Sealing Agents Product Type
Table 23. Date of International Manufacturers Enter into Hemostatic and Tissue Sealing Agents Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemostatic and Tissue Sealing Agents Sales by Type (2016-2021) (K Units)
Table 26. Global Hemostatic and Tissue Sealing Agents Sales Share by Type (2016-2021)
Table 27. Global Hemostatic and Tissue Sealing Agents Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Hemostatic and Tissue Sealing Agents Revenue Share by Type (2016-2021)
Table 29. Hemostatic and Tissue Sealing Agents Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Hemostatic and Tissue Sealing Agents Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Hemostatic and Tissue Sealing Agents Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Hemostatic and Tissue Sealing Agents Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Hemostatic and Tissue Sealing Agents Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Hemostatic and Tissue Sealing Agents Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Hemostatic and Tissue Sealing Agents Sales by Application (2016-2021) (K Units)
Table 36. Global Hemostatic and Tissue Sealing Agents Sales Share by Application (2016-2021)
Table 37. Global Hemostatic and Tissue Sealing Agents Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Hemostatic and Tissue Sealing Agents Revenue Share by Application (2016-2021)
Table 39. Hemostatic and Tissue Sealing Agents Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Hemostatic and Tissue Sealing Agents Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Hemostatic and Tissue Sealing Agents Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Hemostatic and Tissue Sealing Agents Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Hemostatic and Tissue Sealing Agents Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. China Hemostatic and Tissue Sealing Agents Sales (K Units) of Key Companies (2016-2021)
Table 46. China Hemostatic and Tissue Sealing Agents Sales Share by Company (2016-2021)
Table 47. China Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Company (2016-2021)
Table 48. China Hemostatic and Tissue Sealing Agents Revenue Share by Company (2016-2021)
Table 49. China Hemostatic and Tissue Sealing Agents Sales (K Units) by Type (2016-2021)
Table 50. China Hemostatic and Tissue Sealing Agents Sales Share by Type (2016-2021)
Table 51. China Hemostatic and Tissue Sealing Agents Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Type (2016-2021)
Table 53. China Hemostatic and Tissue Sealing Agents Sales (K Units) by Type (2022-2027)
Table 54. China Hemostatic and Tissue Sealing Agents Sales Share by Type (2022-2027)
Table 55. China Hemostatic and Tissue Sealing Agents Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Hemostatic and Tissue Sealing Agents Revenue Share by Type (2022-2027)
Table 57. China Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Type (2022-2027)
Table 58. China Hemostatic and Tissue Sealing Agents Sales (K Units) by Application (2016-2021)
Table 59. China Hemostatic and Tissue Sealing Agents Sales Share by Application (2016-2021)
Table 60. China Hemostatic and Tissue Sealing Agents Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Application (2016-2021)
Table 62. China Hemostatic and Tissue Sealing Agents Sales (K Units) by Application (2022-2027)
Table 63. China Hemostatic and Tissue Sealing Agents Sales Share by Application (2022-2027)
Table 64. China Hemostatic and Tissue Sealing Agents Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Hemostatic and Tissue Sealing Agents Revenue Share by Application (2022-2027)
Table 66. China Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Application (2022-2027)
Table 67. North America Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021) & (K Units)
Table 68. North America Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2016-2021)
Table 69. North America Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2016-2021)
Table 75. Europe Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021) & (K Units)
Table 76. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2016-2021)
Table 77. Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2016-2021)
Table 79. Latin America Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2016-2021)
Table 87. J&J Corporation Information
Table 88. J&J Description and Business Overview
Table 89. J&J Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. J&J Hemostatic and Tissue Sealing Agents Product
Table 91. J&J Recent Development
Table 92. Baxter Corporation Information
Table 93. Baxter Description and Business Overview
Table 94. Baxter Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. Baxter Product
Table 96. Baxter Recent Development
Table 97. C R Bard Corporation Information
Table 98. C R Bard Description and Business Overview
Table 99. C R Bard Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. C R Bard Product
Table 101. C R Bard Recent Development
Table 102. B Braun Corporation Information
Table 103. B Braun Description and Business Overview
Table 104. B Braun Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. B Braun Product
Table 106. B Braun Recent Development
Table 107. Integra Life Sciences Corporation Information
Table 108. Integra Life Sciences Description and Business Overview
Table 109. Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Integra Life Sciences Product
Table 111. Integra Life Sciences Recent Development
Table 112. Advance Medical Solution Corporation Information
Table 113. Advance Medical Solution Description and Business Overview
Table 114. Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Advance Medical Solution Product
Table 116. Advance Medical Solution Recent Development
Table 117. CSL Behring Corporation Information
Table 118. CSL Behring Description and Business Overview
Table 119. CSL Behring Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. CSL Behring Product
Table 121. CSL Behring Recent Development
Table 122. CryoLife Corporation Information
Table 123. CryoLife Description and Business Overview
Table 124. CryoLife Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. CryoLife Product
Table 126. CryoLife Recent Development
Table 127. Zimmer Biomet Corporation Information
Table 128. Zimmer Biomet Description and Business Overview
Table 129. Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Zimmer Biomet Product
Table 131. Zimmer Biomet Recent Development
Table 132. Pfizer Corporation Information
Table 133. Pfizer Description and Business Overview
Table 134. Pfizer Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Pfizer Product
Table 136. Pfizer Recent Development
Table 137. Medtronic Corporation Information
Table 138. Medtronic Description and Business Overview
Table 139. Medtronic Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Medtronic Product
Table 141. Medtronic Recent Development
Table 142. Smith & Nephew Corporation Information
Table 143. Smith & Nephew Description and Business Overview
Table 144. Smith & Nephew Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Smith & Nephew Product
Table 146. Smith & Nephew Recent Development
Table 147. Cohera Medical Corporation Information
Table 148. Cohera Medical Description and Business Overview
Table 149. Cohera Medical Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Cohera Medical Product
Table 151. Cohera Medical Recent Development
Table 152. Shanghai Haohai Biological Technology Co. Ltd. Corporation Information
Table 153. Shanghai Haohai Biological Technology Co. Ltd. Description and Business Overview
Table 154. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. Shanghai Haohai Biological Technology Co. Ltd. Product
Table 156. Shanghai Haohai Biological Technology Co. Ltd. Recent Development
Table 157. Shandong Saikesaisi Biotechnology Co., Ltd Corporation Information
Table 158. Shandong Saikesaisi Biotechnology Co., Ltd Description and Business Overview
Table 159. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. Shandong Saikesaisi Biotechnology Co., Ltd Product
Table 161. Shandong Saikesaisi Biotechnology Co., Ltd Recent Development
Table 162. Chang ShaHai Run biological technology Co, LTD Corporation Information
Table 163. Chang ShaHai Run biological technology Co, LTD Description and Business Overview
Table 164. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 165. Chang ShaHai Run biological technology Co, LTD Product
Table 166. Chang ShaHai Run biological technology Co, LTD Recent Development
Table 167. Hemostatic and Tissue Sealing Agents Market Trends
Table 168. Hemostatic and Tissue Sealing Agents Market Drivers
Table 169. Hemostatic and Tissue Sealing Agents Market Challenges
Table 170. Hemostatic and Tissue Sealing Agents Market Restraints
Table 171. Hemostatic and Tissue Sealing Agents Customers List
Table 172. Hemostatic and Tissue Sealing Agents Distributors List
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic and Tissue Sealing Agents Product Picture
Figure 2. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type in 2020 & 2027
Figure 3. Hemostatic Product Picture
Figure 4. Sealant Gum Product Picture
Figure 5. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application in 2020 & 2027
Figure 6. Minimally Invasive Surgery
Figure 7. General Surgery
Figure 8. Other
Figure 9. Hemostatic and Tissue Sealing Agents Report Years Considered
Figure 10. Global Hemostatic and Tissue Sealing Agents Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hemostatic and Tissue Sealing Agents Market Size 2016-2027 (US$ Million)
Figure 12. Global Hemostatic and Tissue Sealing Agents Sales 2016-2027 (K Units)
Figure 13. Global Hemostatic and Tissue Sealing Agents Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2016-2021)
Figure 15. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region in 2020
Figure 16. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2016-2021)
Figure 17. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region in 2020
Figure 18. Global Hemostatic and Tissue Sealing Agents Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Hemostatic and Tissue Sealing Agents Revenue in 2020
Figure 20. Hemostatic and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2016-2021)
Figure 22. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type in 2020
Figure 23. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2016-2021)
Figure 24. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type in 2020
Figure 25. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2016-2021)
Figure 26. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application in 2020
Figure 27. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2016-2021)
Figure 28. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application in 2020
Figure 29. China Hemostatic and Tissue Sealing Agents Sales Growth Rate 2016-2027 (K Units)
Figure 30. China Hemostatic and Tissue Sealing Agents Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Hemostatic and Tissue Sealing Agents Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Hemostatic and Tissue Sealing Agents Players Market Share by Revenue in Hemostatic and Tissue Sealing Agents in 2020
Figure 33. China Hemostatic and Tissue Sealing Agents Revenue Share by Type (2016-2021)
Figure 34. China Hemostatic and Tissue Sealing Agents Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Hemostatic and Tissue Sealing Agents Revenue Share by Application (2016-2021)
Figure 36. China Hemostatic and Tissue Sealing Agents Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Hemostatic and Tissue Sealing Agents Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Hemostatic and Tissue Sealing Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Hemostatic and Tissue Sealing Agents Sales Market Share by Country in 2020
Figure 40. North America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country in 2020
Figure 41. U.S. Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 42. U.S. Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Hemostatic and Tissue Sealing Agents Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Hemostatic and Tissue Sealing Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Country in 2020
Figure 48. Europe Hemostatic and Tissue Sealing Agents Revenue Market Share by Country in 2020
Figure 49. Germany Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Hemostatic and Tissue Sealing Agents Sales Growth Rate 2016-2021 (K Units)
Figure 60. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Hemostatic and Tissue Sealing Agents Sales Market Share by Region in 2020
Figure 62. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue Market Share by Region in 2020
Figure 63. China Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 64. China Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 66. Japan Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 68. South Korea Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 70. India Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 72. Australia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 74. China Taiwan Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 76. Indonesia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 78. Thailand Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 80. Malaysia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Hemostatic and Tissue Sealing Agents Sales Growth Rate 2016-2021 (K Units)
Figure 82. Latin America Hemostatic and Tissue Sealing Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Hemostatic and Tissue Sealing Agents Sales Market Share by Country in 2020
Figure 84. Latin America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country in 2020
Figure 85. Mexico Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 86. Mexico Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 88. Brazil Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 90. Argentina Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Middle East and Africa Hemostatic and Tissue Sealing Agents Sales Growth Rate 2016-2021 (K Units)
Figure 92. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Middle East and Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Country in 2020
Figure 94. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue Market Share by Country in 2020
Figure 95. Turkey Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 96. Turkey Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Saudi Arabia Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 98. Saudi Arabia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. UAE Hemostatic and Tissue Sealing Agents Sales Growth Rate (2016-2021) (K Units)
Figure 100. UAE Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Hemostatic and Tissue Sealing Agents Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed